A randomized, open-label, multicenter phase 2 study of daratumumab monotherapy for patients (Pts) with intermediate or high-risk smoldering multiple myeloma (SMM): Centaurus Meeting Abstract
| Authors: | Cavo, M.; Hofmeister, C. C.; Chari, A.; Cohen, Y. C.; Spencer, A.; Voorhees, P.; Estell, J.; Venner, C.; Sandhu, I.; Jenner, M.; Williams, C.; van de Donk, N.; Beksac, M.; Kuppens, S.; Bandekar, R.; Neff, T.; Heuck, C.; Qi, M.; Goldschmidt, H.; Ola Landgren, C. |
| Abstract Title: | A randomized, open-label, multicenter phase 2 study of daratumumab monotherapy for patients (Pts) with intermediate or high-risk smoldering multiple myeloma (SMM): Centaurus |
| Meeting Title: | 1st European Myeloma Network Meeting |
| Journal Title: | Haematologica |
| Volume: | 103 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2018 Apr 19-21 |
| Meeting Location: | Turin, Italy |
| ISSN: | 0390-6078 |
| Publisher: | Ferrata Storti Foundation |
| Date Published: | 2018-04-18 |
| Start Page: | 40 |
| End Page: | 41 |
| Language: | English |
| ACCESSION: | WOS:000431395800088 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: P60 -- Source: Wos |
MSK Authors
-
336Landgren